FR-190809 | m-entrepreneurship.com

Product Name :
FR-190809

Search keywords :
FR-190809

drugId :
null

Target Vo:
Acyl coenzyme A:cholesterol acyltransferase 1

Target Vo Short Name :
ACACT1

Moa_Name:
Acyl coenzyme A:cholesterol acyltransferase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Fujisawa Pharmaceutical Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glutathione Peroxidase 4 Antibody
Phospho-CDK1 (Tyr15) Antibody
COX IV Antibody (YA867): COX IV Antibody (YA867) is an unconjugated, approximately 20 kDa, mouse-derived, anti-COX IV (YA867) monoclonal antibody. COX IV Antibody (YA867) can be used for: WB, IHC-F, IHC-P, ICC/IF, IP, FC expriments in human, mouse, rat, hamster, goat, monkey background without labeling.

Author: Betaine hydrochloride

Related Posts